Video, Highlights: Moody’s Analytics Briefs Virginia Appropriators on Revenues, Costs, COVID-19 Vaccine Rollout, “Nailing Jello to the Wall,” etc.

See below for video and a few highlights (including from the invaluable VAPLAN) from Thursday’s Virginia Senate Finance and Appropriations Committee Annual Meeting.

P.S. Also, later in the video, there are additional presentations looking closely at Virginia’s revenues/budget outlook, tax conformity options, Medicaid growth rates (enrollment is rising rapidly), COVID’s impact in K-12 education and school reopening, higher education, transportation, etc.

Full day meeting of the Senate Finance & Appropriations Committee, reviewing revenue and cost projections from numerous sectors of the economy. all streamed online. Agenda here: https://t.co/W0sWi2AzIq and livestream link here: https://t.co/NRjqNVsZk1

— VAPLAN (@vaplan2018) November 19, 2020

• “…once about 25 million Americans have taken that vaccine, in addition to the people who have already been exposed…we should start to see things start to go back to normal.”
• The timeframe on this? Probably late-summer/fall 2021 when we get to that 25 million number. There could be “major upside risk to the forecast” if the vaccine is rolled and distributed faster than this.